TDAC NASDAQ
Translational Development Acquisition Corp.
1W: +0.2%
1M: -0.3%
3M: +1.0%
YTD: +1.6%
1Y: +4.6%
$10.64
-0.02 (-0.19%)
Weekly Expected Move ±0.4%
$11
$11
$11
$11
$11
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$233.1M
52W Range10.19-10.69
Volume4,274
Avg Volume8,207
Beta-0.00
Dividend—
Analyst Ratings
Company Info
CEOMichael Hoffman
Employees2
SectorFinancial Services
IndustryShell Companies
IPO Date2025-02-20
77 Water St Fl 8
New York City, NY 10006
US
New York City, NY 10006
US
16462297549
About Translational Development Acquisition Corp.
Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Jarratt Christopher | 0 | — | 2024-12-20 | |
| Keith Curtis T | 0 | — | 2024-12-20 | |
| TDAC Partners LLC | 4,657,500 | — | 2024-12-20 | |
| Reddy E Premkumar | 0 | — | 2024-12-20 | |
| Kestenbaum Matthew | 0 | — | 2024-12-20 |